Table 1.
Patient # |
sex | age | Site | stage | Histology | Follow-up (months) |
---|---|---|---|---|---|---|
1 | m | 57 | BOT | IV | Squamous cell | 16 |
hypopharynx | IV | Squamous cell | ||||
rt LN | IV | Squamous cell | ||||
2 | m | 84 | palate | IV | Squamous cell | 1 |
3 | m | 72 | BOT | III | Squamous cell | 14 |
4 | m | 71 | Lung | IV | Adenocarcinoma | 5 |
5 | f | 62 | lung | IIIB | Adenocarcinoma | 13 |
6 | f | 70 | Lung | IV | Squamous cell | 3 |
7 | f | 62 | esophagus | IV | Adenocarcinoma | 13 |
8 | m | 65 | maxilla | IV | Squamous cell | 1 |
9 | m | 46 | BOT | I | Squamous cell | 13 |
10 | m | 78 | pancreas | III | Adenocarcinoma | 4 |
11 | m | 71 | rectal | IV | Adenocarcinoma | 12 |
12 | f | 65 | brain | IV | Gliosarcoma | 12 |
13 | f | 45 | Lung | IIIB | Adenocarcinoma | 9 |
14 | f | 67 | uterine | II | Adenocarcinoma | 6 |